We are live on ! Find out more
CCM

Consonance Capital Management Portfolio holdings

AUM $7.28M
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
-43.59%
3 Year Est. Return
+313.86%
5 Year Est. Return
+886.32%
10 Year Est. Return
–
AUM
$672M
AUM Growth
+$70K
Cap. Flow
-$59.1M
Cap. Flow %
-8.79%
Top 10 Hldgs %
64.99%
Holding
33
New
6
Increased
11
Reduced
7
Closed
9

Top Buys

Rank Stock Value
1
CSII
Cardiovascular Systems, Inc.
CSII
+$46.9M
2
ABBV icon
AbbVie
ABBV
+$32.1M
3
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
+$25M
4
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
+$24.4M
5
HMSY
HMS Holdings Corp.
HMSY
+$19.8M

Top Sells

Rank Stock Value
1
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
+$59.1M
2
MYGN icon
Myriad Genetics
MYGN
+$46M
3
AEGR
Aegerion Pharmaceuticals
AEGR
+$35M
4
MASI
Masimo
MASI
+$29.7M
5
UTHR icon
United Therapeutics
UTHR
+$23.4M

Sector Composition

Rank Sector Weight
1 Healthcare 74.34%
2 Industrials 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNDA icon
26
Vanda Pharmaceuticals
VNDA
$304M
– –
-1,226,772
Closed -$19.9M
INFI
27
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-1,262,012
Closed -$15M
ISEE
28
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-311,287
Closed -$11.1M
CLVS
29
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-200,600
Closed -$13.9M
AEGR
30
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-758,970
Closed -$35M
LPDX
31
DELISTED
LIPOSCIENCE INC COM
LPDX
– –
-443,052
Closed -$1.41M
RXII
32
DELISTED
GALENA BIOPHARMA INC COM
RXII
– –
-5,446,469
Closed -$13.6M
1
2

Similar funds

GPC
Garrison Point Capital Walnut Creek, California $6.82M AUM 21.38% 1-Year Est. Return
BPM
Bronson Point Management Fairfield, Connecticut $8.26M AUM 46.43% 1-Year Est. Return
TVPI
True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return
DCI
Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return
TPMI
Tilden Park Management I New York $5.38M AUM 28.49% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
SCG
Siris Capital Group New York $9.42M AUM 42.79% 1-Year Est. Return
CVGI
Craft Ventures GP I San Francisco, California $9.51M AUM 95.77% 1-Year Est. Return

Consonance Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Consonance Capital Management held 33 positions worth $672M, up 0.01% from $672M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Consonance Capital Management withdrew a net $59.1M in Q2 2014, closing 9 positions and reducing 7 holdings. Its most notable exit was Aegerion Pharmaceuticals, an estimated $35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 80% a quarter earlier, followed by Industrials.

Against the trend, Consonance Capital Management opened a new position in Cardiovascular Systems, Inc. worth $50.6M.

  • Consonance Capital Management's largest Q2 2014 buy was Cardiovascular Systems, Inc.: 1,625,120 shares worth $50.6M.
  • Consonance Capital Management added most to WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2014, an estimated $24.4M increase.
  • Consonance Capital Management's biggest Q2 2014 reduction was FURIEX PHARMACEUTICALS INC COM STK (DE), cutting an estimated $59.1M.
  • Consonance Capital Management fully exited Aegerion Pharmaceuticals in Q2 2014, selling an estimated $35M.
  • Consonance Capital Management's ten largest holdings make up 65% of its $672M portfolio in Q2 2014.
  • Consonance Capital Management opened 6 new positions and closed 9 in Q2 2014.
  • Consonance Capital Management's portfolio value rose 0.01% quarter-over-quarter to $672M.

Based on Consonance Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.